Tamoxifen Resistance in Breast Cancer-Reference-Cited by-同舟云学术

Tamoxifen Resistance in Breast Cancer

Published:2001 Issue:12 Volume:61 Page:1721-1733
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Dorssers Lambert C.J.,van der Flier Silvia,Brinkman Arend,van Agthoven Ton,Veldscholte Jos,Berns Els M.J.J.,Klijn Jan G.M.,Beex Louk V.A.M.,Foekens John A.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Reference156 articles.

1. Endogenous Hormones and Breast Cancer Risk

2. Estrogens, Progestogens, Normal Breast Cell Proliferation, and Breast Cancer Risk

3. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis.

4. Steroid-hormone receptors in nonpalpable and more advanced stages of breast cancer. A contribution to the biology and natural history of carcinoma of the female breast

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of mitochondrial/metabolic axis in development of tamoxifen resistance in breast cancer;Human Cell;2023-08-30

2. Structure-Activity Relationship Study Identifies A Novel Lipophilic Amiloride Derivative That Induces Lysosome-Dependent Cell Death in Therapy-Resistant Breast Cancer Cells;2023-05-26

3. Factors Influencing Pharmacokinetics of Tamoxifen in Breast Cancer Patients: A Systematic Review of Population Pharmacokinetic Models;Biology;2022-12-28

4. D/L-Homosistein Tamoksifene Dirençli MCF-7/TAMR-1 Meme Kanseri Hücrelerinin Proliferatif Özelliklerini ER Stresi Aracılı Olarak Baskılayabilir;Süleyman Demirel Üniversitesi Fen Bilimleri Enstitüsü Dergisi;2022-12-20

5. High BRCA1 gene expression increases the risk of early distant metastasis in ER+ breast cancers;Scientific Reports;2022-01-07